digitalstudios

About digitalstudios

This author has not yet filled in any details.
So far digitalstudios has created 4557 blog entries.

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed [...]

By |2026-09-18T14:26:20+00:00September 18, 2026|3rd Party Medical Device Industry News|Comments Off on Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer
Go to Top